Cited by 428Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionEicosanoids and Hypertension Pharmacology

Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension: Evidence That Nitric Oxide Abnormality Is Not Localized to a Single Signal Transduction Pathway

Panza, Julio A., García, Carlos E., Kilcoyne, Crescence M., Quyyumi, Arshed A., Cannon, Richard O.·1995·Circulation

Abstract

Background Patients with essential hypertension have abnormal endothelium-dependent vascular relaxation, largely related to reduced bioactivity of nitric oxide (NO). The purpose of the present investigation was to determine whether this defect is due to a deficit at the specific intracellular signal-transduction pathway level or is a consequence of a more generalized endothelial abnormality. Methods and Results The responses of the forearm vasculature to acetylcholine and bradykinin (endothelium-dependent agents that act through different signal transduction pathways) and to sodium nitroprusside (a direct dilator of vascular smooth muscle) were studied in 10 hypertensive patients (5 men, 5 women; aged 48±9 years old [mean±SD]) and 12 control subjects (6 men, 6 women; aged 48±7 years old). To determine the contribution of NO to bradykinin-induced vasodilation, the vascular responses to bradykinin were also measured after administration of NG-monomethyl-l-arginine, an arginine analogue that inhibits the synthesis of NO. Drugs were infused into the brachial artery, and forearm blood flow was measured by strain-gauge plethysmography. The response to acetylcholine was significantly blunted in hypertensive patients (maximal blood flow, 7.5±2 versus 16.6±8 mL · min−1· 100 mL−1 in control subjects [mean±SD];P<.005). Similarly, the vasodilator effect of bradykinin was significantly reduced in hypertensive patients compared with control subjects (maximal blood flow, 8.7±2 versus 15.8±6 mL · min−1· 100 mL−1 in control subjects;P<.005). A significant correlation was found between the maximal blood flow with acetylcholine and that with bradykinin (r=.89). No significant differences were found between the two groups for vascular response to sodium nitroprusside.NG-monomethyl-l-arginine significantly blunted the response to bradykinin in control subjects (maximal blood flow decreased from 15.8±6 to 10.1±2 mL · min−1· 100 mL−1,P<.003). In contrast, inhibition of NO synthesis did not modify the response to bradykinin in hypertensive patients (maximal blood flow, 8.7±2 and 8.5±3 before and during infusion of NG-monomethyl-l-arginine, respectively;P=NS). As a consequence, the response to bradykinin after inhibition of NO synthesis was not significantly different between the two groups. Conclusions Patients with essential hypertension have impaired endothelium-dependent vasodilator responses to both acetylcholine and bradykinin. These findings indicate that the endothelial dysfunction in this condition is not related to a specific defect of a single intracellular signal-transduction pathway and suggest a more generalized abnormality of endothelial vasodilator function.

Integrity signals

Registry

Crossref · 10.1161/01.cir.91.6.1732

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sepiapterin supplementation improves endothelial function in several mouse models, including atherosclerosis ApoE−/− mice, diabetes models, and obesity models.

    “Sepiapterin supplementation improves endothelial function in several mouse models, including the atherosclerosis model ApoE−/− mice (560), diabetes models (721), or obesity models (527).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Panza, J. A., García, C. E., Kilcoyne, C. M., Quyyumi, A. A., & Cannon, R. O.
Affiliations
National Institutes of Health (US)
Venue
Circulation
Published
1995-03-15
Volume
91
Issue
6
Pages
1732-1738
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2035929496
Cited by
428
References
57
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 12 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 5
FWCI
22.09
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
essential hypertension, endothelium-dependent vasodilation, nitric oxide, acetylcholine, bradykinin, L-NMMA, forearm blood flow, signal transduction, endothelial dysfunction, sodium nitroprusside, vasorelaxation, brachial artery, forearm circulation, endothelium-independent relaxation, nitric oxide synthase
MeSH terms
Acetylcholine, Adult, Arginine, Arm, Bradykinin, Female, Humans, Hypertension, Male, Middle Aged, Nitric Oxide, Nitroprusside, Regional Blood Flow, Vascular Resistance, Vasodilation, Signal Transduction, omega-N-Methylarginine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review